Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- IOVA -33.1%, ORGO -19.9%, WOLF -18.7%, CVRX -17.1%, RCEL -14.8%, GMED -14.6%, DCGO -13.3%, ONTO -11.7%, FIGS -11.5%, HROW -10.4%, EXPE -9.9%, XPOF -9.1%, KODK -8.2%, FLWS -7.8% (also names new CEO), INOD -7.4%, OS -7.4%, OUT -7%, AFRM -6.7%, SUZ -6.6%, SPT -6.4%, REAL -6.3%, GRND -6.3%, SLVM -5.3%, ZIP -4.9%, SG -4.8%, OCS -4.2%, HUBS -4.1% (also authorizes new $500 mln share repurchase program), INGM -3.7% (also increases dividend), PBA -3.6%, COLL -3.6%, PCRX -3.3%, MNST -3.2%, CLMT -3.1%, COMP -3%, BILL -2.7%, ZYME -2.7%, HUBG -2.6%, SYNA -2.6%, GSAT -2.4%, CLSK -2.3%, SOLV -2.3%, SOUN -2.1%, ILMN -2%, AKAM -1.9%, WULF -1.8%, BBDC -1.7%, EXFY -1.6%, ASTH -1.5%, COIN -1.4% (also files mixed securities shelf offering), RKT -1.4%, MARA -1.3%, BHF -1.3%, SATS -1.3%, AAOI -1.1%, STWD -1%
Other news:
- CTLP -7.9% (partnership with Carnival Cruise)
- TYRA -5.6% (files for $500 mln mixed securities shelf offering)
- TH -5.2% (to delay 10-Q filing)
- PRTC -2.8% (announces the publication of new research in BMC Pulmonary Medicine that provides a comprehensive view into the lived experiences of people with idiopathic pulmonary fibrosis)
- CDTX -2.3% (files for $500 mln mixed securities shelf offering)
- QUBT -1.2% (names new COO)
- CNS -0.8% (reports April AUM)